Literature DB >> 30125242

Managing disruptive behaviour in autism-spectrum disorder with guanfacine.

Lukas Propper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30125242      PMCID： PMC6158025     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  14 in total

1.  Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.

Authors:  Lawrence Scahill; James T McCracken; Bryan H King; Carol Rockhill; Bhavik Shah; Laura Politte; Roy Sanders; Mendy Minjarez; Jennifer Cowen; Jennifer Mullett; Chris Page; Denise Ward; Yanhong Deng; Sandra Loo; James Dziura; Christopher J McDougle
Journal:  Am J Psychiatry       Date:  2015-08-28       Impact factor: 18.112

2.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  2005-11

3.  Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.

Authors:  Daniel F Connor; Robert L Findling; Scott H Kollins; Floyd Sallee; Frank A López; Andrew Lyne; Gerald Tremblay
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

4.  A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures.

Authors:  Laura C Politte; Lawrence Scahill; Janet Figueroa; James T McCracken; Bryan King; Christopher J McDougle
Journal:  Neuropsychopharmacology       Date:  2018-02-27       Impact factor: 7.853

5.  Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Authors:  Randall Owen; Linmarie Sikich; Ronald N Marcus; Patricia Corey-Lisle; George Manos; Robert D McQuade; William H Carson; Robert L Findling
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

6.  Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.

Authors:  Floyd R Sallee; James McGough; Tim Wigal; Jessica Donahue; Andrew Lyne; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-02       Impact factor: 8.829

7.  A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

Authors:  Ronald N Marcus; Randall Owen; Lisa Kamen; George Manos; Robert D McQuade; William H Carson; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-11       Impact factor: 8.829

8.  Impact of ADHD symptoms on autism spectrum disorder symptom severity.

Authors:  Linda Sprenger; Eva Bühler; Luise Poustka; Christiane Bach; Monika Heinzel-Gutenbrunner; Inge Kamp-Becker; Christian Bachmann
Journal:  Res Dev Disabil       Date:  2013-08-22

9.  Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial.

Authors:  Karen Bearss; Cynthia Johnson; Tristram Smith; Luc Lecavalier; Naomi Swiezy; Michael Aman; David B McAdam; Eric Butter; Charmaine Stillitano; Noha Minshawi; Denis G Sukhodolsky; Daniel W Mruzek; Kylan Turner; Tiffany Neal; Victoria Hallett; James A Mulick; Bryson Green; Benjamin Handen; Yanhong Deng; James Dziura; Lawrence Scahill
Journal:  JAMA       Date:  2015-04-21       Impact factor: 157.335

Review 10.  The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?

Authors:  Yael Leitner
Journal:  Front Hum Neurosci       Date:  2014-04-29       Impact factor: 3.169
View more
  1 in total

1.  Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.

Authors:  Amy F T Arnsten
Journal:  Neurobiol Learn Mem       Date:  2020-10-17       Impact factor: 2.877
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.